Knock, Knock – FDA Issues Guidance on Best Processes and Practices During BIMO Inspections
FDA Law
JUNE 10, 2024
In an effort to clarify for industry and alleviate some of the stress associated with these activities, last week the FDA issued a draft guidance aimed at providing recommendations on how to handle inspections under FDA’s Bioresearch Monitoring (BIMO) program. Provide both completed and planned actions and related timelines.
Let's personalize your content